N/A
N=183
Cell Phone Messaging to Improve Communication of Critical Laboratory Results to Patients in Rural Uganda
HIV · Tuberculosis
Bottom Line
View on ClinicalTrials.gov: NCT01579214 ↗Enrolled (actual)
183
Serious AEs
0.0%
Results posted
Dec 2017
Primary outcome: Primary: Participants Initiating Antiretroviral Therapy (ART) Within 28 Days of Abnormal Result — 8; 89 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Cellular Phone Text Messages (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Massachusetts General Hospital
- Primary completion
- Dec 2013
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Participants Initiating Antiretroviral Therapy (ART) Within 28 Days of Abnormal Result |
8; 89 | — |
| SECONDARY Clinic Return Within 28 Days of Abnormal CD4 Count Result |
22; 128 | — |
Summary
The investigators will study the efficacy of a novel cellular phone messaging system to communicate health information and facilitate early return to clinic after abnormal laboratory results in rural Uganda.
Eligibility Criteria
Inclusion Criteria
- HIV positive
- Active in care at Mbarara Regional Referral Hospital HIV Clinic
- Undergoing laboratory testing
- Self-reported cell phone access
- Agrees to participation and gives informed consent
Exclusion Criteria
- Age < 18
- Resides outside great Mbarara area (Mbarara, Isingiro, Kyruhuura, Ibanda, or Ntungamo districts)
Data sourced from ClinicalTrials.gov (NCT01579214). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.